Advanced Biomedical Research
Synthetic curcumin: An update on efficacy and safety
Authors
School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, Madhya Pradesh, India
| 1. |
Lüer SC, Goette J, Troller R, Aebi C. Synthetic versus natural curcumin: bioequivalence in an in vitro oral mucositis model. BMC Complement Altern Med 2014;14:53.  |
| 2. |
Jain R. Nature identical curcumin. Int J Appl Basic Med Res 2013;3:134. |
| 3. |
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-900. |
| 4. |
Ravindran J, Subbaraju GV, Ramani MV, Sung B, Aggarwal BB. Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro. Biochem Pharmacol 2010;79:1658-66. |
| 5. |
Borra SK, Gurumurthy P, Mahendra J, Jayamathi KM, Cherian CN, Chand R. Antioxidant and free radical scavenging activity of curcumin determined by using different in vitro and ex vivo models. J Med Plants Res 2013;7:2680-90. |
| 6. |
Venkata M, Sripathy R, Anjana D, Somashekara N, Krishnaraju A, Krishanu S, et al. In silico, In vitro and In vivo assessment of safety and anti-inflammatory activity of curcumin. Am J Infect Dis 2012;8:26-33.
|
)